This is a guest login. You can create a regular account or login to an existing one.

Parnax Lab Ltd.

Add to My Investments

Healthcare | Drugs & Pharma

we think vacations are for wimps

37 Stocks to buy right now

Join now and be among the first to discover Stock Ideas

Get the Stocks!

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1982

Chairman: Prakash M Shah

Managing Director: Baiju M Shah

Group: --

Listing: BSE: 506128

Headquarters: Mumbai, Maharashtra

Website: www.naxparlab.com

Key Facts

Market cap: R 15.78 Cr

Revenue (TTM): R 89.82 Cr

Earnings (TTM): R 0.12 Cr

Cash: R 0.60 Cr

Total Debt: R 41.94 Cr

Promoters' ownership: 62.59%

Liquidity: Low

52 Week range: R 15.60 - 47.90

Face value: R10.00

Shares outstanding: 85,04,866

Stock Performance

Trailing
Annual

Time Period	Parnax Lab Ltd.	S&P BSE Healthcare	S&P BSE Small Cap
YTD	-58.84	-3.93	-9.34
1 month	-9.92	3.23	-0.09
3 months	-36.10	2.71	2.46
1 Year	-61.52	-3.46	-8.04
3 Years	-18.50	-4.82	2.94
5 Years	-15.65	-2.19	3.79
10 Years	--	10.48	5.28

As on 13-Dec-2019

Year	Parnax Lab Ltd.	S&P BSE Small Cap	S&P BSE Healthcare
2018	-26.24	-23.41	-5.89
2017	87.42	59.64	0.49
2016	-47.42	1.77	-12.88
2015	85.62	6.76	15.06
2014	-42.20	69.24	47.43
2013	-11.46	-11.23	22.55
2012	-62.37	32.76	38.28

Annual Report (FY19)

News & Announcements